Delivery Order SPE2DR25D1100-SPE2DR26FCQ0D
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,244.58 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) on November 12, 2025, with a completion date of December 4, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,874.06 to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count units). This competitively awarded, firm fixed-price contract was issued on November 4, 2025, with an ultimate completion date of November 26, 2025. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $4,027.70 by the Defense Logistics Agency on September 8, 2025, for the supply of Ingrezza 80 mg capsules (30-count). This non-set-aside competitive award is scheduled for completion by September 29, 2025, and represents a single transaction under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,676.11 to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count) on November 5, 2025, with an ultimate completion date of November 28, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $7,352.24 to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count) on August 25, 2025, with an ultimate completion date of September 16, 2025. This firm fixed price delivery order represents a non-competitive award and will be fulfilled from the vendor's place of business in Conshohocken, Pennsylvania. The contract is structured as a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) valued at $3,676.12. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 7, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's demonstrated capability to...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.69 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) on November 5, 2025, with an ultimate completion date of November 28, 2025. This firm fixed-price, non-set-aside contract represents a competitive award for pharmaceutical products supporting federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Ingrezza 80 mg capsules (30-count) with a ceiling value of $4,027.69. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for completion by...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on November 6, 2025, for $4,027.69 to supply Ingrezza 80 mg capsules (30-count units). This is a firm fixed-price contract with a completion date of December 1, 2025, and no set-aside designation was used. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 14, 2025, for Ingrezza 40 mg capsules (30-count). This competitively awarded, firm fixed-price delivery order has a ceiling value of $3,676.12 and is scheduled for completion by September 5, 2025. The contract utilizes no set-aside designation and represents a child award under AmerisourceBergen's substantial...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCQ0DDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,874.06 on November 18, 2025, for the supply of Ingrezza 40 mg capsules (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 10, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's $999.99 billion IDC with DLA Troop Support Medical, extending through December 2026, provides comprehensive global pharmaceutical support across multiple therapeutic domains, including specialty medications, generic and brand-name drugs, vaccines, and specialized medical supplies. This delivery order for Ingrezza—a neurological treatment medication—exemplifies the company's ongoing role in supplying pharmaceutical products to support Defense Health Agency operations and other federal healthcare systems. AmerisourceBergen's federal contract portfolio demonstrates consistent success in competitive procurement across a diverse range of medical commodities and transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 11/18/25 |